シュレーディンガー Official site

[Live Stream 6/27] Schrödinger Digital Drug Discovery Seminar: Into the Clinic - The Transformation of the Drug Discovery Process Brought by Computational Chemistry - Session 2

シュレーディンガー

We would like to invite you to the second seminar where researchers involved in the Schrödinger drug discovery research project will introduce examples of computational chemistry drug discovery and provide an opportunity for questions and answers from the audience. We welcome broad participation from those who are interested in the latest technologies in quantitative simulation, the further efficiency of the DMTA (Design-Make-Test-Analyze) cycle enhanced by experimental validation, and those who are eager to engage in next-generation drug discovery research. ■ Theme of the Second Seminar In Silico Driven Drug Discovery of a Zwitterionic Integrin αvβ6 Development Candidate for Fibrosis ■ Speaker Aleksey Gerasyuto Vice President, Drug Discovery, Head of Chemistry, Schrödinger Therapeutics Group *Participation from other companies in the same industry is discouraged.